Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 10Neoplasm Metastasis 5Sarcoma 4Neoplasms 4Hematologic Neoplasms 4Breast Neoplasms 4Brain Neoplasms 4Pancreatic Neoplasms 3Melanoma 3Glioma 3Thyroid Cancer, Papillary 2Salivary Gland Neoplasms 2Prostatic Neoplasms 2Ovarian Neoplasms 2Neoplasms by Site 2Neoplasms by Histologic Type 2Lymphoproliferative Disorders 2Leukemia, Myeloid, Acute 2Central Nervous System Neoplasms 2Wilms Tumor 1Uveal Melanoma 1Thrombocytosis 1Solid Tumors 1Solid Tumor 1Sarcoma, Ewing 1Recurrence 1Rare Tumour 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Noonan Syndrome 6 1

Interventions

pembrolizumab 14Injections 13Paclitaxel 10Nivolumab 10Docetaxel 9Cisplatin 9Capecitabine 9Bevacizumab 8toripalimab 7senaparib 7Fluorodeoxyglucose F18 7Cyclophosphamide 7tislelizumab 6atezolizumab 6Irinotecan 6Fluorouracil 6Gemcitabine 5fludarabine 4apatinib 4Oxaliplatin 4Leucovorin 4Ipilimumab 4spartalizumab 3pertuzumab 3olaparib 3camrelizumab 3Rifampin 3Radiosurgery 3Midazolam 3Itraconazole 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Solid Tumor × entrectinib × Clear all
NCT03961100 2020-09-07

A Performance and Bioavailability Study of Entrectinib in Healthy Volunteers.

Genentech, Inc.

Phase 1 Completed
31 enrolled 14 charts
Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡